A UK watchdog is urging women on GLP-1 weight-loss drugs like Ozempic and Mounjaro to use effective forms of birth control after receiving more than 40 pregnancy-related reports linked to the ...

Weight-loss drugs could stop hormone replacement therapy from working and increase the associated risks, guidance has warned.

With three months since its launch in India, according to latest Pharmatrac data, Mounjaro clocked Rs 12.6 crore in sales in May 2025—a threefold increase from March ...

A new side effect from the weight loss drug is making people take another look at the potential dangers surrounding its use.

A MOTHER has revealed that despite losing over three stone thanks to Mounjaro, she has been hit with some unfortunate side effects. Chloe Mckernan, 32, a mum-of-two from Glasgow who is currently ...

A Queensland fashion influencer renowned for empowering women over size 12 has opened up about copping criticism from her followers and the pressure to explain her changing body.

Ro Weight Loss, a digital health service from Roman Health Ventures Inc., has updated its official website to provide new ...

Eli Lilly & Co. sees 60% sales increase for weight-loss drug Mounjaro in India, tapping into growing market demand.

Novo Nordisk's popular weight-loss and diabetes drugs Wegovy and Ozempic may in very rare cases cause a serious eye condition ...

Researchers at the University of Toronto have found GLP-1 weight loss and diabetes drugs like Ozempic and Mounjaro double the ...

This fast growth has created some high expectations for Hims & Hers stock. It now has a price-to-earnings ratio (P/E) of 79, ...

The European Medicines Agency warns that Novo Nordisk's Ozempic and Wegovy may, in rare cases, cause NAION—a serious eye condition that can lead to vision loss. The EMA has asked the company to update ...